To study the effects of a psychostimulant (MDMA) on responses to affective touch in individuals with a range of autistic traits.
Country United States of America
Visit trial
Status
Planned
Results Published
No
Start date
08 August 2019
End date
12 April 2021
Chance of happening
100%
Phase
Phase I
Design
Blinded
Type
Interventional
Generation
First
Participants
24
Sex
All
Age
21- 40
Therapy
No
Trial Details
To study the effects of a psychostimulant (MDMA) on responses to affective touch in individuals with a range of autistic traits.NCT Number NCT04053036
Sponsors & Collaborators
University of CincinnatiThis company doesn't have a full profile yet, it is linked to a clinical trial.